|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Molecular Insight Pharmaceuticals, Inc. (MIPI) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
15 |
|
|
|
Total
Direct Shares :
|
3,019,059 |
|
|
Total
Indirect Shares :
|
4,768,526 |
| |
%
Held by Insiders:
|
11.99% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Barlow David S |
10% Owner |
2011-01-28 |
2,361,377 |
|
0 |
| Frank Daniel |
Director |
2009-10-06 |
146,959 |
2007-11-28 |
0 |
| Wallroth Donald E. |
Former Chief Financial Officer |
2009-09-28 |
37,500 |
2008-05-20 |
0 |
| Gottlieb Scott |
Director |
2009-05-29 |
4,000 |
2009-05-29 |
0 |
| Lafrance Norman D. |
Sr. VP Clinical Dev and CMO |
2009-05-28 |
16,657 |
2007-11-29 |
0 |
| Mccray John E |
Chief Operating Officer |
2008-05-20 |
187,103 |
2008-05-20 |
33,201 |
| Babich John W |
President/Chief Scientific Off, Director |
2008-05-20 |
185,906 |
2008-05-20 |
17,629 |
| Hamermesh Joshua |
VP Comm & Bus Development |
2008-03-31 |
20,833 |
2008-03-31 |
0 |
| Kronauge James F |
VP Process Development |
2007-11-27 |
48,224 |
|
0 |
| Stylli Harry |
Director |
2007-02-02 |
7,500 |
2007-02-02 |
0 |
| Lamon Kim D |
Director |
2007-02-01 |
3,000 |
2007-02-01 |
0 |
| Sterling Lionel N |
Director |
2007-02-01 |
0 |
2007-02-01 |
235,228 |
| Feinberg Stephen |
10% Owner |
2007-02-01 |
0 |
2007-03-30 |
3,753,306 |
| Qvt Fund Lp |
|
|
0 |
2010-06-27 |
364,581 |
| Quintessence Fund L.p. |
|
|
0 |
2010-06-27 |
364,581 |
|
|
